2002
DOI: 10.1104/pp.102.010918
|View full text |Cite
|
Sign up to set email alerts
|

Two Putative BIN2 Substrates Are Nuclear Components of Brassinosteroid Signaling

Abstract: GSK3 is a highly conserved kinase that negatively regulates many cellular processes by phosphorylating a variety of protein substrates. BIN2 is a GSK3-like kinase in Arabidopsis that functions as a negative regulator of brassinosteroid (BR) signaling. It was proposed that BR signals, perceived by a membrane BR receptor complex that contains the leucine (Leu)-rich repeat receptor-like kinase BRI1, inactivate BIN2 to relieve its inhibitory effect on unknown downstream BR-signaling components. Using a yeast (Sacc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
196
0
2

Year Published

2007
2007
2020
2020

Publication Types

Select...
4
4
1

Relationship

1
8

Authors

Journals

citations
Cited by 220 publications
(207 citation statements)
references
References 41 publications
9
196
0
2
Order By: Relevance
“…To test ATBS1-AIF4 interaction, the ORF of At3g06590 was PCR amplified and cloned into pACT2 vector (Clontech). The pAS2-BIN2 and pACT2-BES1/BZR1 constructs used as controls were described previously (Zhao et al, 2002).…”
Section: Yeast Two-hybrid Screening and Assaymentioning
confidence: 99%
See 1 more Smart Citation
“…To test ATBS1-AIF4 interaction, the ORF of At3g06590 was PCR amplified and cloned into pACT2 vector (Clontech). The pAS2-BIN2 and pACT2-BES1/BZR1 constructs used as controls were described previously (Zhao et al, 2002).…”
Section: Yeast Two-hybrid Screening and Assaymentioning
confidence: 99%
“…Unlike animal steroids that move into cells to bind intracellular receptors, BRs are perceived at the cell surface by the leucine-rich repeat receptor-like kinase BRASSINOSTEROID-INSENSITIVE1 (BRI1) that initiates a phosphorylation-mediated signaling cascade (Li and Chory, 1997;Li, 2005). In the absence of BRs, BRI1 and its coreceptor BRI1-Associated receptor Kinase (BAK1) are inactive kinases Nam and Li, 2002;Wang et al, 2005a), while a GSK3-like kinase BRASSINOSTEROID-INSENSITIVE2 (BIN2) is constitutively active to phosphorylate two highly similar transcription factors, bri1-EMS-Suppressor 1 (BES1) and BrassinazoleResistant1 (BZR1) Wang et al, 2002;Yin et al, 2002;Zhao et al, 2002), thus promoting their degradation, retaining them in cytosol, and/or inhibiting their DNA binding activity (Vert and Chory, 2006;Bai et al, 2007;Gampala et al, 2007;Ryu et al, 2007). BR binding to BRI1 triggers a rapid dissociation of BRI1 Kinase Inhibitor1 from BRI1 and promotes heterotetramerization and transphosphorylation of BRI1 and BAK1 (Wang et al, 2005bWang and Chory, 2006), leading to phosphorylation of BR-signaling kinases and inhibition of BIN2 (Peng et al, 2008;Tang et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…On the opposite, another BRI1-interacting protein, BKI1, negatively regulates BR signaling by limiting the association of BRI1 and BAK1 [17]. BIN2 is a GSK3-like protein and negatively controls BR signaling by phosphorylating two nuclear components BES1 and BZR1 [18,19]. As nuclear transcription factors, the unphosphorylated BES1 and BZR1 can activate the expressions of BRresponsive genes to promote plant growth (BZR1 also inhibits the expression of BR biosynthetic genes), while the phosphorylated BES1 loses its DNA-binding activity to the BR-responsive genes, and phosphorylated BZR1 is rapidly degraded by proteasome to relieve its feedback inhibition of several BR biosynthetic genes [20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%
“…Activation of BRI1 leads to interaction with, and activation of, another receptor kinase, BAK1, which has been proposed to act as BRI1's coreceptor (9,10). Downstream of the receptor kinases, the BIN2 kinase and BSU1 phosphatase regulate the phosphorylation status of BZR1 and BZR2/BES1 (11)(12)(13)(14). BR activate BZR1 and BZR2/BES1 by inducing their dephosphorylation, possibly by inhibiting BIN2 or activating BSU1.…”
mentioning
confidence: 99%